Table 1.
Odds Ratio | p-Value | 95% Confidence Interval | Probability for CE if Characteristic present | Probability for CE if Characteristic absent | |
---|---|---|---|---|---|
IgHV | |||||
IgHV unmutated (N = 63/84) | 1.142 | 0.797 | 0.414–3.146 | 0.413 | 0.381 |
High-risk Genomic Abnormalities at Trial Enrollment | |||||
TP53 Loss and/or Mutation (N = 14/86) | 1.667 | 0.384 | 0.527–5.270 | 0.500 | 0.375 |
ATM Loss and/or Mutation (N = 34/86) | 1.12 | 0.801 | 0.463–2.707 | 0.412 | 0.385 |
Treatment Arm | |||||
FCR (N = 40/86) | 2.806 | 0.024 | 1.149–6.851 | 0.525 | 0.283 |
Response | |||||
Complete Response (N = 16/84) | 1.720 | 0.333 | 0.574–5.152 | 0.500 | 0.368 |
Non-response (N = 10/84) | 0.629 | 0.525 | 0.150–2.626 | 0.300 | 0.405 |